NON SMALL CELL LUNG CANCER STAGE III
Clinical trials for NON SMALL CELL LUNG CANCER STAGE III explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CANCER STAGE III trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CANCER STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test guides targeted therapy to prevent lung cancer return
Disease control Recruiting nowThis study looks at people with early-stage non-small cell lung cancer who have finished standard treatment. A blood test checks for tiny bits of cancer DNA (ctDNA) that might mean the cancer could come back. If the test is positive, participants get a drug called durvalumab to t…
Matched conditions: NON SMALL CELL LUNG CANCER STAGE III
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
New combo therapy aims to shrink lung tumors before surgery
Disease control Recruiting nowThis study tests whether giving chemotherapy plus an immunotherapy drug (cemiplimab) before surgery can help people with stage 3 lung cancer that has spread to certain lymph nodes. About 21 adults will receive four cycles of the combination, then undergo surgery to remove the can…
Matched conditions: NON SMALL CELL LUNG CANCER STAGE III
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
New pill offers hope for lung cancer patients who can't have standard treatment
Disease control Recruiting nowThis study tests a drug called sotorasib (AMG510) in people with stage III lung cancer that has a specific KRAS G12C mutation and cannot be removed by surgery. Participants take the drug before and after initial treatment to see if it helps keep the cancer from growing. About 43 …
Matched conditions: NON SMALL CELL LUNG CANCER STAGE III
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Virus therapy shows promise for tough lung cancers
Disease control Recruiting nowThis study tests a new approach for people with advanced lung cancer whose disease got worse after standard first-line treatment. Participants receive an experimental virus (Olvi-Vec) followed by chemotherapy plus an immunotherapy drug, or the standard chemotherapy docetaxel alon…
Matched conditions: NON SMALL CELL LUNG CANCER STAGE III
Phase: PHASE2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC
-
Breathing new life: exercise program aims to ease shortness of breath in advanced lung cancer
Symptom relief Recruiting nowThis study looks at whether pulmonary rehabilitation—a program of exercise and breathing techniques—can improve breathing, fatigue, and quality of life for people with advanced non-small cell lung cancer. Half of the 85 participants will do an 8-week rehab program, while the othe…
Matched conditions: NON SMALL CELL LUNG CANCER STAGE III
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 12, 2026 12:06 UTC
-
New radiation technique aims to protect heart during cancer treatment
Knowledge-focused Recruiting nowThis study tests whether a newer, MRI-guided radiation method (MRgART) is gentler on the heart than standard radiation for people with lung, esophageal, or other chest cancers. About 60 adults will receive radiation and undergo heart MRIs and blood tests to see how their heart fu…
Matched conditions: NON SMALL CELL LUNG CANCER STAGE III
Phase: PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:54 UTC
-
Lung cancer study tracks immune system after combo treatment
Knowledge-focused Recruiting nowThis study observes 50 people with stage III non-small cell lung cancer who have already received chemotherapy and radiation, followed by immunotherapy. Researchers want to see how the immune system responds and how long patients live without the cancer getting worse. The study d…
Matched conditions: NON SMALL CELL LUNG CANCER STAGE III
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated Jun 05, 2026 12:07 UTC